In a recent issue of Molecular Cancer Therapeutics , Burgess and colleagues ([1][1]) give a detailed biochemical and functional characterization of AMG 102, a fully humanized monoclonal antibody to hepatocyte growth factor (HGF). HGF, or scatter factor, is the only known high-affinity ligand for the
No takes yet. Share an insight, caveat, or question.
Yap et al. (2010) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: